RSS Feed Link

eMed Blog

Funding insights for entrepreneurs from top med tech investors

At the MedTech Investing Conference in Minneapolis last week, two sessions focused specifically on med tech funding: from early- and late-stage investing to emerging funding sources available to private companies.

[More]
Christina Hernandez Sherwood
on May 13, 2013
Category:  Creation 
The FDA’s med tech priorities – and what they mean for entrepreneurs

At the MedTech Investing Conference in Minneapolis on Wednesday, Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health outlined the administration's key priorities related to the med tech industry.

[More]
Christina Hernandez Sherwood
on May 10, 2013
Category:  Execution 
The state of the med tech venture industry

Medical devices have outperformed most other sectors in the venture industry from 2001 to last year. But a capital crunch remains.

[More]
Christina Hernandez Sherwood
on May 08, 2013
Category:  Creation 
At MedTech Investing Conference, "Med tech is alive and well"

"Med tech is alive and well, despite what we hear out there," Kevin Wasserstein, founder and principal at MentorCatalyst, told the attendees of today's MedTech Investing Conference.

[More]
Christina Hernandez Sherwood
on May 08, 2013
Category:  Creation 
Event Preview: MedTech Investing Conference

Medical technology innovators and investors from across the country will gather Wednesday in Minneapolis for the 12th annual MedTech Investing Conference. With panels on alternative funding models, maximizing ROI, and the FDA on the agenda, we asked conference co-chair Dennis Wahr, CEO of Holaira, what insights life science and digital health entrepreneurs can expect to take away from the event.

[More]
Christina Hernandez Sherwood
on May 06, 2013
Category:  Creation 
Event Preview: MedTech Investing Conference

Medical technology innovators and investors from across the country will gather Wednesday in Minneapolis for the 12th annual MedTech Investing Conference. With panels on alternative funding models, maximizing ROI, and the FDA on the agenda, we asked conference co-chair Dennis Wahr, CEO of Holaira, what insights life science and digital health entrepreneurs can expect to take away from the event.

[More]
Christina Hernandez Sherwood
on May 06, 2013
Category:  Creation 
  • 1